DRUG · Unmapped registry intervention
DE-126 Ophthalmic Solution 0.002% QD
Find medicine records ·
Find other trials using this name
Clinical trial
Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT04742283
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Timolol Maleate Ophthalmic Solution 0.5% BID
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMulticenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Primary Open Angle Glaucomaunresolved
Interventions
Sponsors & collaborators
Santen Inc.lead sponsor
Mapped research locations
JacksonvilleFlorida, United States3San AntonioTexas, United States2Las VegasNevada, United States2Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1CincinnatiOhio, United States1DurhamNorth Carolina, United States1PhoenixArizona, United States1AuroraColorado, United States1RochesterNew York, United States1Salt Lake CityUtah, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04742283 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.